Issue 11, 2026, Issue in Progress
From the journal:

RSC Advances

Correction: Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases

Qiwen Jiang,a   Mengni Jiang,a   Yanwei Lv,a   Xinyuan Zhang,b   Shige Wang*b  and  Jiulong Zhao*a  

* Corresponding authors

a Department of Gastroenterology, Shanghai Institute of Pancreatic Diseases, Changhai Hospital, National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, China
E-mail: jlzhao9@163.com

b School of Materials and Chemistry, University of Shanghai for Science and Technology, No. 516 Jungong Road, Shanghai, China
E-mail: sgwang@usst.edu.cn

Abstract

Correction for ‘Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases’ by Qiwen Jiang et al., RSC Adv., 2025, 15, 36344–36364, https://doi.org/10.1039/D5RA04662A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D6RA90023B
Article type
Correction
Submitted
10 Feb 2026
Accepted
10 Feb 2026
First published
19 Feb 2026
This article is Open Access
Creative Commons BY license

RSC Adv., 2026,16, 9756-9756

Permissions

Request permissions

Correction: Disulfiram as an anti-inflammatory agent: mechanisms, nano-delivery strategies, and applications in non-oncologic diseases

Q. Jiang, M. Jiang, Y. Lv, X. Zhang, S. Wang and J. Zhao, RSC Adv., 2026, 16, 9756 DOI: 10.1039/D6RA90023B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements